Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | Medical Cannabis and Wellness Equity |
| Investment focus | Equity, North America, Health Care |
| Fund size | EUR 9 m |
| Total expense ratio | 0.80% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Strategy risk | Long-only |
| Sustainability | No |
| Fund currency | USD |
| Currency risk | Currency unhedged |
| Volatility 1 year (in EUR) | - |
| Inception/ Listing Date | 9 January 2020 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Ireland |
| Fund Provider | HANetf |
| Fund Structure | Open-ended Investment Company (OEIC) |
| UCITS compliance | Yes |
| Administrator | J.P. Morgan Administration Services (Ireland) Limited |
| Investment Advisor | |
| Custodian Bank | J.P. Morgan SE - Dublin Branch |
| Revision Company | Ernst and Young |
| Fiscal Year End | 31 March |
| Swiss representative | Waystone |
| Swiss paying agent | Helvetische Bank AG |
| Germany | Unknown |
| Switzerland | No ESTV Reporting |
| Austria | Non-Tax Reporting Fund |
| UK | UK Reporting |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | |
| Securities lending | No |
| Securities lending counterparty |
| Jazz Pharmaceuticals | 20.89% |
| Innovative Industrial | 14.39% |
| Scotts Miracle-Gro Co. | 14.28% |
| AMYRIS ORD | 11.94% |
| ARENA PHARMACEUTICALS ORD | 10.58% |
| GrowGeneration | 6.82% |
| Hydrofarm Holdings Group | 5.33% |
| CARA Therapeutics | 1.70% |
| 22ND CENTURY GROUP ORD | 1.41% |
| AGRIFY ORD SHS | 1.08% |
| United States | 74.01% |
| Ireland | 20.89% |
| Canada | 2.26% |
| Israel | 1.06% |
| Health Care | 39.41% |
| Basic Materials | 26.88% |
| Real Estate | 14.73% |
| Industrials | 7.42% |
| Other | 11.56% |
| YTD | - |
| 1 month | +0.00% |
| 3 months | +16.80% |
| 6 months | -7.08% |
| 1 year | - |
| 3 years | - |
| 5 years | - |
| Since inception (MAX) | - |
| 2025 | - |
| 2024 | - |
| 2023 | - |
| 2022 | - |
| Volatility 1 year | - |
| Volatility 3 years | - |
| Volatility 5 years | - |
| Return per risk 1 year | - |
| Return per risk 3 years | - |
| Return per risk 5 years | - |
| Maximum drawdown 1 year | - |
| Maximum drawdown 3 years | - |
| Maximum drawdown 5 years | - |
| Maximum drawdown since inception | - |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| XETRA | EUR | CBSX | CBSXIV | CBSXEURINAV=SOLA | Goldenberg Hehemeyer LLP |